Cero Therapeutics Holdings, Inc. (CERO) EBIT (2022 - 2026)
Cero Therapeutics Holdings (CERO) recorded EBIT of -$3.85 million in Q2 2026, compared with -$4.72 million a year earlier.
Cero Therapeutics Holdings, Inc. (CERO) EBIT (2022 - 2026) Analysis & Trends
On a TTM basis, Cero Therapeutics Holdings' EBIT came in at -$17.48 million as of Jun 30, 2026; for FY2025, it was -$18.46 million.
- Across earlier years, EBIT came in at -$15.3 million in FY2024, -$7.68 million in FY2023, -$2.91 million in FY2022 and -$332,415 in FY2021.
- The Q2 2026 figure is the highest quarterly EBIT since Q4 2024.
- Per Business Quant, the preceding three quarters came in at -$4.85 million (Q1 2026), -$4.43 million (Q4 2025) and -$4.36 million (Q3 2025).
Peer Comparison
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.85 Mn |
| Mar 31, 2026 | -4.85 Mn |
| Dec 31, 2025 | -4.43 Mn |
| Sep 30, 2025 | -4.36 Mn |
| Jun 30, 2025 | -4.72 Mn |
| Mar 31, 2025 | -4.95 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | -4.40 Mn |
| Jun 30, 2024 | -5.15 Mn |
| Mar 31, 2024 | -3.65 Mn |
| Dec 31, 2023 | -1.12 Mn |
| Sep 30, 2023 | -1.54 Mn |
| Jun 30, 2023 | -2.41 Mn |
| Mar 31, 2023 | -2.44 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -836,685.00 |
| Jun 30, 2022 | -376,580.00 |
Cero Therapeutics Holdings, Inc. EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=CERO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "CERO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=CERO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();